Back

Extracellular Vesicle Biomarkers in the Aqueous Humor Correlate with Retinoblastoma Seeding

Peng, C.-C.; Amacker, A.; Goni, N.; Attem, J.; Sirivolu, S.; Berry, J. L.; Xu, L.

2026-06-02 cancer biology
10.64898/2026.06.01.728823 bioRxiv
Show abstract

PurposeTo investigate the correlation of retinoblastoma (RB) aqueous humor (AH)-derived extracellular vesicle (EV) surface markers, particularly CD133, with clinical features of RB. MethodsAH samples (n=22) collected at diagnosis (n=17) or primary enucleation (n=5) from RB eyes were profiled using magnetic bead-based flow cytometry. Median fluorescence intensities (MFI) of tetraspanins (CD9, CD63, CD81) and CD133 were quantified and correlated with International Intraocular RB Classification (IIRC) stage, seeding location, seeding morphology, and enucleation. ResultsCD133+ EVs were detected in 16 of 22 (73%) samples. While CD133 levels showed a non-significant increasing trend with advanced IIRC stages, CD133 expression was significantly elevated in eyes with vitreous seeding vs. subretinal only (P = 0.010). Cuzicks trend analysis revealed a significant association between rising CD133 % MFI and complex seeding (P < 0.001). Conversely, CD63 displayed a significant inverse trend, with decreasing % MFI associated with complex seeding (P < 0.001). CD133high eyes (MFI>10,000, n=9) exhibited increased enucleation (P = 0.007) and predominantly sphere/cloud seeding patterns (P = 0.001). CD133high eyes demonstrated a coordinated CD63/CD81 co-expression pattern (r = 0.80), absent in the CD133low group. ConclusionsElevated CD133 level and percentage were associated with vitreous involvement and complex seeding morphology, suggesting potential as a minimally invasive indicator of disease burden. The inverse relationship between CD63 and seeding severity, combined with CD63/CD81 remodeling in CD133high eyes, suggests an EV profile indicative of aggressive disease. These findings support the association of CD133+ EVs with advanced RB seeding and warrant further prospective validation.

Matching journals

The top 12 journals account for 50% of the predicted probability mass.

1
PLOS ONE
4510 papers in training set
Top 11%
15.7%
2
Scientific Reports
3102 papers in training set
Top 4%
11.1%
3
British Journal of Cancer
42 papers in training set
Top 0.1%
7.3%
4
Translational Vision Science & Technology
35 papers in training set
Top 0.3%
2.8%
5
Ophthalmology Science
20 papers in training set
Top 0.1%
2.2%
6
Investigative Ophthalmology & Visual Science
22 papers in training set
Top 0.2%
1.9%
7
Journal of Clinical Medicine
91 papers in training set
Top 3%
1.8%
8
International Journal of Molecular Sciences
453 papers in training set
Top 6%
1.8%
9
Investigative Opthalmology & Visual Science
37 papers in training set
Top 0.4%
1.8%
10
Frontiers in Immunology
586 papers in training set
Top 4%
1.6%
11
Cancers
200 papers in training set
Top 3%
1.4%
12
F1000Research
79 papers in training set
Top 3%
1.0%
50% of probability mass above
13
JCI Insight
241 papers in training set
Top 5%
1.0%
14
Clinical Epigenetics
53 papers in training set
Top 0.8%
1.0%
15
Journal of Translational Medicine
46 papers in training set
Top 2%
0.9%
16
Diagnostics
48 papers in training set
Top 2%
0.9%
17
Pathogens
53 papers in training set
Top 1%
0.9%
18
Frontiers in Pharmacology
100 papers in training set
Top 4%
0.8%
19
Experimental Dermatology
10 papers in training set
Top 0.2%
0.8%
20
Angiogenesis
15 papers in training set
Top 0.2%
0.8%
21
npj Genomic Medicine
33 papers in training set
Top 0.7%
0.8%
22
Laboratory Investigation
13 papers in training set
Top 0.2%
0.8%
23
Eye
11 papers in training set
Top 0.3%
0.8%
24
Clinical and Translational Science
21 papers in training set
Top 0.9%
0.8%
25
Frontiers in Cell and Developmental Biology
218 papers in training set
Top 8%
0.8%
26
Gene Reports
13 papers in training set
Top 0.6%
0.8%
27
Nature Communications
4913 papers in training set
Top 62%
0.8%
28
Biomolecules
95 papers in training set
Top 2%
0.8%
29
Acta Neuropathologica Communications
81 papers in training set
Top 1%
0.8%
30
Biochemistry and Biophysics Reports
28 papers in training set
Top 1%
0.8%